Evidence map›Paper›PMID 30200514›Full record

ArticleViruses2018

Antiviral Activity of Fermented Ginseng Extracts against a Broad Range of Influenza Viruses.

Ye Wang, Yu-Jin Jung, Ki-Hye Kim, Youngman Kwon, Yu-Jin Kim, Zhan Zhang, Heun-Soo Kang, Bao-Zhong Wang, Fu-Shi Quan, Sang-Moo Kang

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Antiviral Potential of the GenusJournal of ginseng research · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Toxicity as prime selection criterion among SARS-active herbal medications.Phytomedicine : international journal of phytotherapy and phytopharmacology · 2021
    Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 3 countries.

Ye WangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. ywang91@student.gsu.edu.
Yu-Jin JungCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. yjung8@student.gsu.edu.
Ki-Hye KimCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. kihyekim4282@gmail.com.
Youngman KwonCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. ymankwon@gmail.com.
Yu-Jin KimCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. yujinsm@gmail.com.
Zhan ZhangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. zzhang12@student.gsu.edu.
Heun-Soo KangMetabolab, Cancer Research Institute, Seoul National University College of Medicine, Seoul 110-799, Korea. metabolab@gmail.com.
Bao-Zhong WangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. bwang23@gsu.edu.ORCID 0000-0002-1561-4318
Fu-Shi QuanCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. fquan01@gmail.com.
Sang-Moo KangCenter for Inflammation, Immunity and Infection, Institute for Biomedical Sciences Georgia State University, Atlanta, GA 30303, USA. skang24@gsu.edu.
Georgia State University · USSeoul National University · KR

Funding

Influenza vaccines inducing broadly cross protective immunityR01AI093772 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2011 to 2020
$4.2M
VLP Vaccine TechnologyR01AI105170 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2013 to 2017
$3.7M
Perioperative Telemonitoring to Optimize Cancer Care and OutcomesR21NR019866 · NINR · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI MELSTROM, LALEH · 2021 to 2022
$440k
LAIV Inducing Cross ProtectionR21AI119366 · NIAID · GEORGIA STATE UNIVERSITY · PI KANG, SANG-MOO · 2015 to 2016
$415k
NIAID NIH HHS R01 AI093772NIAID NIH HHS R01 AI105170NIAID NIH HHS R21 AI119366NINR NIH HHS R21 NR019866
6 · The paper itself

Abstract

Ginseng products used as herb nutritional supplements are orally consumed and fermented to ginsenoside compounds by the intestinal microbes. In this study, we investigated antiviral protective effects of fermented ginseng extracts against different strains of influenza viruses in genetically diverse mouse models. Intranasal coinoculation of mice with fermented ginseng extract and influenza virus improved survival rates and conferred protection against H1N1, H3N2, H5N1, and H7N9 strains, with the efficacy dependent on the dose of ginseng samples. Antiviral protection by fermented ginseng extract was observed in different genetic backgrounds of mice and in the deficient conditions of key adaptive immune components (CD4, CD8, B cell, MHCII). The mice that survived primary virus inoculation with fermented ginseng extract developed immunity against the secondary infection with homologous and heterosubtypic viruses. In vitro cell culture experiments showed moderate virus neutralizing activity by fermented ginseng extract, probably by inhibiting hemagglutination and neuraminidase activity. This study suggests that fermented ginseng extracts might provide a means to treat influenza disease regardless of virus strains.

Indexed as

AnimalsAntiviral AgentsDisease Models, AnimalDogsHemagglutinin Glycoproteins, Influenza VirusMadin Darby Canine Kidney CellsMiceNeuraminidaseOrthomyxoviridaeOrthomyxoviridae InfectionsPanaxPlant ExtractsSurvival AnalysisVirus InternalizationAntiviral AgentsHemagglutinin Glycoproteins, Influenza VirusNeuraminidasePlant Extractsantiviral activityfermented ginsenghemagglutinininfluenza virusneuraminidase

Identifiers

PMID30200514
PMCPMC6164659
OpenAlexW2890511793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.